SS
Steve Seedhouse Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
31
Avg Return
Past Year
Past Year
21%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $22 |
54%
upside
| 3 | +21% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Strong Buy
Upgraded
| $123 |
34%
upside
| 1 | +74% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $91 |
125%
upside
| 1 | +6.6% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $266 |
61%
upside
| 1 | +20% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $40 |
24%
upside
| 1 | +0.88% |
0
%
| 19 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $41 |
441%
upside
| 1 | +46% |
0
%
| 5 Feb ‘26 2 months ago |
|